Abstracts

130 – A Multistage Sampling Approach to Refine HIV Mortality Estimates in KwaZulu-Natal, South Africa

Background As the global response to HIV intensifies toward the goal of ending the epidemic by 2030, accurate estimates of mortality among people with HIV are needed to appropriately allocate limited resources. Standard patient monitoring approaches frequently lead to misclassification of patient outcomes, including vital status. In South Africa, the national HIV electronic health record…

116 – DOLPHIN-Moms: Pharmacokinetics of Dolutegravir and HIV Viral Suppression With 1HP or 3HP in Pregnancy

Background The World Health Organization endorses 3 months of weekly isoniazid and rifapentine (3HP) as TB preventive therapy (TPT) in people with HIV (PWH) on once-daily dolutegravir (DTG)-based antiretroviral treatment (ART). Optimal dosing of DTG to maintain HIV viral suppression in pregnancy while taking 3HP or 1 month of daily isoniazid and rifapentine (1HP) has…

200 – Ensitrelvir to Prevent COVID-19 in Households: SCORPIO-PEP Phase III Placebo-Controlled Trial Results

Background Ensitrelvir is an oral SARS-CoV-2 3CL protease inhibitor, approved in Japan for the treatment of mild-moderate COVID-19. No approved antivirals have been proven efficacious as post-exposure prophylaxis (PEP) in household contacts (HHC) of index patients (IP) with COVID-19. Methods SCORPIO-PEP was a double-blind, placebo-controlled trial in HHC of IP with laboratory-confirmed COVID-19 conducted in…

191 – Long-Acting Cabotegravir PrEP Uptake and Persistence in a Large US Healthcare System

Background Long-acting cabotegravir (CAB-LA) was approved as HIV preexposure prophylaxis (PrEP) in the U.S. in December 2021, but data are limited on use in clinical practice. We evaluated CAB-LA uptake and persistence in an integrated healthcare system and compared early CAB-LA adopters to individuals dispensed oral PrEP only. Methods We extracted electronic health records of…

185 – Low-Cost Counseling Achieves Positive Outcomes for Malawi Men Disengaged From Care: Randomized Trial

Background Men’s suboptimal HIV treatment outcomes hinder epidemic control efforts and jeopardize men’s health. Interventions tailored to men’s unique needs are essential, although rarely tested. We tested the effect of person-centered care interventions on ART engagement among men living with HIV but not in care in Malawi. Methods We conducted an individually randomized control trial…